Description
Tirzepatide Research Peptide
Tirzepatide is a synthetic dual GIP/GLP-1 receptor agonist supplied for controlled laboratory investigation. Its structure includes 39 amino acids with a C-20 fatty diacid moiety, enabling its specific interaction profile. Researchers study its impact on glucose-dependent insulinotropic signaling, providing a foundation for repeatable studies under standardized conditions.
Because its dual agonism targets both GIP and GLP-1 receptors, researchers value its utility in dissecting complex metabolic signaling pathways. Emphasizing controlled environments ensures data consistency, allowing scientists to precisely examine specific incretin pathway activation patterns and their downstream interaction behavior, which is crucial for understanding its compound-specific mechanisms.
In laboratory settings, Tirzepatide is handled following standard peptide preparation and safety procedures. This compound is supplied as a lyophilized powder. Store in cool, dry conditions. After reconstitution with bacteriostatic water, refrigerate at 2-8°C. For extended storage, freeze at -20°C, ensuring compound integrity for subsequent research protocols.
The consistent composition of Tirzepatide reduces experimental variation, offering high suitability for long-term laboratory projects. This consistency ensures compatibility with structured research workflows, enabling reliable data generation across multiple experimental phases and supporting robust, reproducible scientific inquiry.
Ongoing research includes Tirzepatide due to its defined sequence and stable behavior. Its suitability for controlled research models allows for precise investigation into glucose-dependent insulinotropic signaling pathways and their broader physiological implications.
Important Notice: Tirzepatide 10mg is provided strictly for research use only. This product is not intended for human or animal use, clinical applications, diagnostic procedures, or consumption of any kind. All research must be conducted by qualified professionals in appropriate laboratory environments and in compliance with applicable regulations and guidelines.
Frequently Asked Questions
What is Tirzepatide?
Tirzepatide is a synthetic 39-amino acid peptide, classified as a dual GIP/GLP-1 receptor agonist. Its molecular structure includes a C-20 fatty diacid moiety, which is integral to its pharmacological profile. It is supplied for laboratory research to investigate its mechanisms of action on incretin pathways, with a CAS number of 2023788-19-2.
What is the structural significance of Tirzepatide’s C-20 fatty diacid moiety?
The C-20 fatty diacid moiety within Tirzepatide’s structure is critical for its extended half-life and receptor interaction in research models. This modification facilitates albumin binding, which reduces renal clearance and prolongs its systemic availability, allowing for sustained investigation of its effects on GIP and GLP-1 receptor activation in controlled settings.
What biological systems are studied using Tirzepatide?
Researchers primarily use Tirzepatide to study biological systems involved in glucose homeostasis and metabolic regulation. This includes investigation of the incretin system, pancreatic islet cell function, and glucose-dependent insulinotropic signaling pathways in various in vitro and in vivo laboratory models.
How does Tirzepatide’s dual agonism function in research models?
In research models, Tirzepatide’s dual agonism functions by simultaneously activating both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This concurrent activation leads to a synergistic response, modulating glucose-dependent insulin secretion and influencing other metabolic processes under controlled experimental conditions.
Why is Tirzepatide of interest in metabolic research?
Tirzepatide is of significant interest in metabolic research due to its unique dual agonistic mechanism targeting both GIP and GLP-1 receptors. This allows researchers to explore the intricate interplay of these incretin hormones in glucose regulation, energy homeostasis, and associated signaling pathways, providing a comprehensive tool for metabolic studies.
What are the recommended storage conditions for Tirzepatide?
For optimal stability and research integrity, Tirzepatide should be stored as a lyophilized powder in cool, dry conditions away from direct light. After reconstitution with bacteriostatic water, the solution should be refrigerated at 2-8°C. For extended storage periods, it is recommended to freeze the reconstituted peptide at -20°C.
Reviews
There are no reviews yet.